Belgium· BE-AMP-SAM247493-00

Ambirix

A kombinationen (hepatitis a + hepatitis b) product containing hepatitis b virus surface antigen (recombinant), registered in Belgium by GlaxoSmithKline Biologicals. The same ATC class is registered in 11 of our 19 countries.

ATC J07BC20

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedAmbirixATCJ07BC20REGISTER NO.BE-AMP-SAM247493-00PACKS LISTED0CHECKEDSeptember 26, 2026

Where it is registered

Kombinationen (hepatitis a + hepatitis b) is registered in 11 of 19 countries.

Countries holding a registration under ATC J07BC20 (kombinationen (hepatitis a + hepatitis b)), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 7 of them publish a price we can compare per daily dose

Kombinationen (hepatitis a + hepatitis b) · ATC J07BC20

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Hepatitis B virus surface antigen (recombinant)
Manufacturer
GlaxoSmithKline Biologicals
Country
Belgium (BE)
ATC code
J07BC20
ATC class
Kombinationen (Hepatitis A + Hepatitis B)
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/3fc73007-745e-4544-a34c-b9a99f5d6ef1
GET /v1/drugs/3fc73007-745e-4544-a34c-b9a99f5d6ef1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Suspension for injection",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Ambirix",
  "name_fr": "Ambirix",
  "name_nl": "Ambirix",
  "amp_code": "SAM247493-00",
  "strengths": null,
  "pack_count": 5,
  "substances": [
    "Hepatitis B virus surface antigen (recombinant)",
    "Hepatitis A Virus Antigene (Hav Antigen) Vaccin",
    "Sodium Chloride"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Combinations",
  "authorisation_numbers": [
    "EU/1/02/224/001",
    "EU/1/02/224/002",
    "EU/1/02/224/003",
    "EU/1/02/224/004",
    "EU/1/02/224/005"
  ]
}

See everything about kombinationen (hepatitis a + hepatitis b).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.